التفاصيل البيبلوغرافية
| العنوان: |
Investigator‐blinded, controlled, and randomized comparative study on 1565 nm non‐ablative fractional laser versus 5% minoxidil for treatment of androgenetic alopecia. |
| المؤلفون: |
Qu, Huanhuan, Zhang, Rongli, Xin, Wuyan, Jing, Huan, Wang, Gang, Gao, Lin |
| المصدر: |
Journal of Cosmetic Dermatology; May2024, Vol. 23 Issue 5, p1638-1644, 7p |
| مصطلحات موضوعية: |
MINOXIDIL, HAIR transplantation, HAIR removal, HAIR growth, BALDNESS, HAIR follicles, LASERS |
| مستخلص: |
Background: Characterized by progressive hair loss due to an excessive response to androgens, androgenetic alopecia (AGA) affects up to 50% of males and females. Minoxidil is one of approved medications for AGA but inadequate responses occur in many patients. Aims: To determine whether 1565 nm non‐ablative fractional laser (NAFL) could yield better therapeutic benefits for patients with AGA as compared with 5% minoxidil. Methods: Thirty patients with AGA were enrolled; they were randomly assigned into the laser or minoxidil treatment groups. For the laser treatment group, patients were treated by 1565 nm NAFL at 10 mJ, 250 spots/cm2 with 2 weeks intervals for 4 sessions in total. For the minoxidil treatment group, 1‐milliliter of topical 5% minoxidil solution was applied to hair loss area twice a day. Results: The primary outcomes were the changes in numerous hair growth indexes at the Week 10 as compared with the baselines. Both 1565 nm NAFL and 5% minoxidil led to significantly greater hair densities and diameters in patients at the Week 10 than the baselines (p < 0.01). As compared with 5% minoxidil, 1565 nm NAFL showed significantly greater improvements in total hair number, total hair density (hair/cm2), terminal hair number, terminal hair density (hair/cm2), number of hair follicle units, and average hair number/number of hair follicle units. Conclusions: Our data demonstrate that 1565 nm NAFL exhibits superior clinical efficacy in some aspects of hair growth to the topical minoxidil. It is a safe and effective modality in treating AGA. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Cosmetic Dermatology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder